Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Derya Kivrak,Salim

第一单位： Department of Medical Oncology, Akdeniz University Hospital, School of Medicine, Antalya 07059, Turkey.

作者： Derya Kivrak,Salim ^[1] ; Hasan,Mutlu ^[1] ; Melek Karakurt,Eryilmaz ^[1] ; Ozan,Salim ^[2] ; Fatma Yalçin,Musri ^[1] ; Deniz,Tural ^[1] ; Şeyda,Gündüz ^[3] ; Hasan Şenol,Coşkun ^[1]

作者单位： Department of Medical Oncology, Akdeniz University Hospital, School of Medicine, Antalya 07059, Turkey. ^[1] Department of Hematology, Akdeniz University Hospital, School of Medicine, Antalya 07059, Turkey. ^[2] Department of Medical Oncology, Antalya Training and Research Hospital, Antalya 07100, Turkey. ^[3]

关键词 head and neck cancer neutrophil to lymphocyte ratio prognosis survival

DOI 10.3892/mco.2015.557

PMID 26171192

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览27

Molecular and clinical oncology

2015年3卷4期

839-842页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

检索历史清除